Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human AVPR1A Antibodies:
anti-Mouse (Murine) AVPR1A Antibodies:
anti-Rat (Rattus) AVPR1A Antibodies:
Go to our pre-filtered search.
Human Monoclonal AVPR1A Primary Antibody for WB - ABIN1882193
Thibonnier, Auzan, Madhun, Wilkins, Berti-Mattera, Clauser: Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. in The Journal of biological chemistry 1994
Show all 4 Pubmed References
Expression of oxytocin and vasopressin (show AVP Antibodies) receptors in the equine conceptus between Days 10 and 16 of pregnancy.
The data of this study indicated that alterations in amygdala signalling may constitute a neural mechanism by which polymorphisms of the AVPR1A gene could influence ASD (show ARSD Antibodies) susceptibility.
These results demonstrate that polymorphisms in the AVPR1A promoter region might be involved in pathophysiology of ASD (show ARSD Antibodies) and in functional regulation of the expression of AVPR1A.
Overall, our study establishes continuity between the existing AVPR1a research in clinical and non-clinical populations. Our results suggest that vasopressin (show AVP Antibodies) may exert its effects on social behaviour in part by modulating attentional focus between social and non-social cues.
Three OXTR (show OXTR Antibodies) polymorphisms (rs2270465, rs2268493, rs7632287) and 2 AVPR1A polymorphisms (rs1587097, rs1042615) showed nominal effects (p < .05) on vocal symptoms, of which 1 (rs1587097) remained significant after correcting for multiple testing (p = .003). Study found potential mediation of the effect of the OXTR (show OXTR Antibodies) rs2268493 polymorphism on vocal symptoms through levels of cortisol.
Using a mixed mediation and moderation model, study found that the gray matter volume of the right fusiform face area mediated the association between AVPR1A RS3 (show EDAR Antibodies) and altruistic behavior. Moreover, this mediation effect was significant only in male subjects.
Genetic variation in the vasopressin (show AVP Antibodies) 1a receptor was found not to be associated with circulatory or renal failure, but with the presence of coagulation failure in patients with acute decompensation of liver cirrhosis and acute-on-chronic liver failure.
The gene-based analysis indicated association of variation within AVPR1A with aggressive behavior. We conclude that common variants at 2p12 show suggestive evidence for association with childhood aggression.
Association between neural activation of the anterior prefrontal cortex in mothers and fathers in response to their child smiling video stimuli to induce the positive affect related to attachment with their child, and genetic variants of OT receptor (OXTR (show OXTR Antibodies)) and AVP (show AVP Antibodies) receptor 1A (AVPR1A).
Study used brainstem tissue containing this region in order to validate a reliable, pharmacologically informed receptor autoradiography protocol for use in human brain tissue more broadly and to establish where OXTR (show OXTR Antibodies) and AVPR1a are expressed in adjacent regions in the human brainstem.
Mothers with long alleles for AVPR1a and DRD4 (show DRD4 Antibodies) engaged in more mother-oriented social cognition, which in turn predicted less sensitive maternal behavior. There were no significant direct effects of AVPR1a or DRD4 (show DRD4 Antibodies) on maternal sensitivity (beta = 0.02, P = .73 and beta = -0.10, P = .57, respectively).
depressive-like behavior alters oxytocin receptor (OxtR (show OXTR Antibodies)) and arginine vasopressin (show AVP Antibodies) receptor type 1a (AvpR1a) gene expression in the hippocampus (HC) of male mice.
Data indicate the upregulation of vasopressin receptor 1 (V1R) expression on hepatocytes upon liver ischemia-reperfusion injury (IRI).
Data show that cryptochrome Cry1 (show CRY1 Antibodies) and Cry2 (show CRY2 Antibodies) expression must be circadian and appropriately phased to support rhythms, and arginine vasopressin (AVP (show AVP Antibodies)) receptor signaling is required to impose circuit-level circadian function.
The results suggest that vasopressin (show AVP Antibodies) receptor is required for conditioned effects of an ethanol-associated social stimulus
Local over-expression of the AVP (show AVP Antibodies) receptor V1a enhances regeneration of atrophic muscle.
Oxytocin inhibits ASICs through V1A receptors in sensory neurons modulating nociception and pain.
Transaortic constriction decreased heart function and betaAR density. It increased V1AR expression. V1AR decreased cardiomyocyte betaAR ligand affinity, betaAR-induced calcium signaling and cAMP in a Gq protein-independent/G protein receptor kinase-dependent way.
Using homologous recombination in mice, we reveal the modest contribution of proximal 5' flanking sequences to species differences in V1aR distribution, and confirm that variation in V1aR distribution impacts stress-coping in the forced swim test.
Central V1a receptors might play an important role in suppressing baroreflex control of heart rate during cerebral activation at the onset of voluntary locomotion.
V1aR signaling may be fundamentally important for the expression of AQP2 (show AQP2 Antibodies) in the collecting ducts during control conditions and dehydration
The protein encoded by this gene acts as receptor for arginine vasopressin. This receptor belongs to the subfamily of G-protein coupled receptors which includes AVPR1B, V2R and OXT receptors. Its activity is mediated by G proteins which stimulate a phosphatidylinositol-calcium second messenger system. The receptor mediates cell contraction and proliferation, platelet aggregation, release of coagulation factor and glycogenolysis.
arginine vasopressin receptor 1A
, vasopressin V1a receptor-like
, SCCL vasopressin subtype 1a receptor
, V1-vascular vasopressin receptor AVPR1A
, V1a vasopressin receptor
, antidiuretic hormone receptor 1A
, vascular/hepatic-type arginine vasopressin receptor
, vasopressin V1a receptor
, AVPR V1a
, V1a arginine vasopressin receptor
, antidiuretic hormone receptor 1a
, arginine vasopressin receptor V1a
, Antidiuretic hormone receptor 1a
, Vascular/hepatic-type arginine vasopressin receptor